Animal-Free Recombinant Human IL-13

Product Code: GFC0540

Catalog Number Unit Size Price
GFC0540-2µg 2µg Online Inquiry
GFC0540-10µg 10µg Online Inquiry
GFC0540-50µg 50µg Online Inquiry
GFC0540-100µg 100µg Online Inquiry
GFC0540-250µg 250µg Online Inquiry
GFC0540-500µg 500µg Online Inquiry
GFC0540-1mg 1mg Online Inquiry

Description

IL-13 is an immunoregulatory cytokine produced primarily by activated Th2 cells, and also by mast cells and NK cells. Targeted deletion of IL-13 in mice resulted in impaired Th2 cell development and indicated an important role for IL-13 in the expulsion of gastrointestinal parasites. IL-13 exerts anti-inflammatory effects on monocytes and macrophages and it inhibits the expression of inflammatory cytokines such as IL-1b, TNF-a, IL-6 and IL-8. IL-13 has also been shown to enhance B cell proliferation and to induce isotype switching, resulting in increased production of IgE. Blocking of IL-13 activity inhibits the pathophysiology of asthma. Human and murine IL-13 are cross-species reactive. Recombinant Rat IL-13 a 12.3 kDa protein consisting of 113 amino acid residues.

Specification

Sample Resource
E.coli
Purity
≥ 98% by SDS-PAGE gel and HPLC analyses.
Synonyms
NC300 (Human), P600 (Murine)
AA Sequence
MSPGPVPPST ALRELIEELV NITQNQKAPL CNGSMVWSIN LTAGMYCAAL ESLINVSGCS AIEKTQRMLS GFCPHKVSAG QFSSLHVRDT KIEVAQFVKD LLLHLKKLFR EGRFN
Biological Activity
Determined by its ability to stimulate the proliferation of human TF-1 cells. The expected ED50 is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥1 x 106 units/mg.
Calculated Molecular Weight
12.6 kDa
Accession Number
P35225
Gene ID
3596
For research or further manufacturing use only. Not for use in humans.

CONTACT US

USA
Europe

ABOUT US

As a pioneer of biotechnology, Creative Bioarray has developed into a leading biotechnology company in the world. We are committed to providing our customers with innovative high-quality products and services through discovering, developing, and manufacturing.

Copyright © 2024 Creative Bioarray. All rights reserved.